[1]纪岩磊,韩 真,邵丽梅,等.经肝动脉化疗栓塞术、经门静脉化疗栓塞术联合高强度聚焦超声治疗门静脉癌栓的临床研究[J].介入放射学杂志,2015,(03):256-260.
 JI Yan lei,HAN Zhen,SHAO Li mei,et al.Combination use of TACE, PVE and HIFU for the treatment of portal vein cancerous thrombus: a clinical study[J].journal interventional radiology,2015,(03):256-260.
点击复制

经肝动脉化疗栓塞术、经门静脉化疗栓塞术联合高强度聚焦超声治疗门静脉癌栓的临床研究 ()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2015年03期
页码:
256-260
栏目:
临床研究
出版日期:
2015-03-25

文章信息/Info

Title:
Combination use of TACE, PVE and HIFU for the treatment of portal vein cancerous thrombus: a clinical study
作者:
         纪岩磊 韩 真 邵丽梅 李云凌 赵 珑 赵月环
Author(s):
JI Yan lei HAN Zhen SHAO Li mei LI Yun ling ZHAO Long ZHAO Yue huan.
Department of Special Examination, Shandong Provincial Cancer Hospital, Jinan, Shandong Province 250117, China
关键词:
【关键词】 原发性肝癌 门静脉癌栓 肝动脉化疗栓塞 门静脉化疗栓塞 高强度聚焦超声
文献标志码:
A
摘要:
【摘要】 目的 观察经肝动脉化疗栓塞术(TACE)、经门静脉化疗栓塞术(PVE)联合高强度聚焦超声(HIFU)治疗原发性肝癌合并门静脉癌栓的临床疗效。方法 分析2011年1月至2012年2月收治的原发性肝癌合并门静脉癌栓患者85例,TACE、PVE联合HIFU治疗47例为观察组,TACE、PVE治疗38例为对照组,TACE治疗后2周行PVE,PVE后10 d左右行HIFU治疗。结果 观察组的近期有效率为89.4%(42/47),对照组为39.5%(15/38),两组比较差异有统计学意义(P < 0.05)。观察组6个月、1年、2年的生存率为87.2%(41/47)、66.0%(31/47)、27.7%(13/47),中位生存期15.4个月,对照组上述时间点生存率分别为55.3%(21/38)、39.5%(15/38)和10.5%(4/38),中位生存期10.3个月,两组比较差异有统计学意义(P < 0.05)。结论 TACE、PVE联合HIFU治疗原发性肝癌门静脉癌栓可显著提高疗效,延长生存时间,是一种较为安全、有效的治疗方法。

参考文献/References:

[1] 程树群, 李 楠, 吴孟超. 门静脉癌栓分型与治疗选择[J]. 中国普外基础与临床杂志, 2012, 19: 240 242.
[2] Shi J, Lai EC, Li N, et al. A new classification for hepatocellular carcinoma with portal vein tumor thrombus[J]. J Hepatobiliar Pancr Sci, 2011, 18: 74 80.
[3] 张伟杰, 杨甲梅. 原发性肝癌合并门静脉癌栓的治疗现状[J]. 肝胆外科杂志, 2005, 13: 314 316.
[4] 翁敬飚, 阮海兰, 韦 玲, 等. 原发性肝癌并发门静脉癌栓临床探讨[J]. 重庆医学, 2010, 39: 2344 2345, 2347.
[5] Schwartz JD, Schwartz M, Mandeli J, et al. Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials[J]. Lancet Oncol, 2002, 3: 593 603.
[6] Biolato M, Marrome G, Racco S, et al. Transarterial chemoembolization (TACE) for unresectable HCC: a new life begins?[J]. Eur Rev Med Pharmacol Sci, 2010, 14: 356 362.
[7] 张 磊, 陆骊工, 李 勇, 等. 门静脉支架联合肝动脉化疗栓塞治疗肝癌伴门静脉癌栓的临床研究[J]. 介入放射学杂志, 2011, 20: 968 973.
[8] 谢印法, 李 敏, 赵月环, 等. TACE + PVE综合治疗原发性肝癌并门脉癌栓[J]. 肿瘤防治研究, 2010, 37: 951 952.
[9] 崔 林, 吴兴军, 余扬群, 等. 经皮肝穿刺门静脉化疗栓塞治疗原发性肝癌门静脉癌栓[J]. 中国癌症杂志, 2005, 15: 381 382.
[10]裴 峰, 徐周敏, 李 勇, 等. 高强度聚焦超声与伽玛刀治疗门静脉癌栓的对比观察[J]. 中国肿瘤临床, 2010, 37: 1127 1129.
[11]周宏平, 冯志洪, 赵 峰, 等. 高强度聚焦超声治疗门静脉栓塞临床研究[J]. 徐州医学院学报, 2007, 27: 550 553.
[12]周宁宁, 钟春生, 顾蔼洁, 等. 高强度聚集超声治疗原发性肝癌合并门静脉癌栓24例临床疗效观察[J]. 淮海医药, 2010, 28: 328 329.

相似文献/References:

[1].关于召开“全国肝癌介入治疗研讨会”的通知[J].介入放射学杂志,1995,(04):200.
[2]高 嵩,朱旭,杨仁杰,等. TACE联合奥沙利铂、氟尿嘧啶、亚叶酸钙肝动脉化疗治疗中晚期原发性肝癌[J].介入放射学杂志,2012,(05):377.
 ,,et al. TACE combined with hepatic arterial infusion chemotherapy using oxaliplatin, 5fluorouracil and folinic acid for intermediate and advanced hepatocellular carcinomas[J].journal interventional radiology,2012,(03):377.
[3]程洪涛,郭晨阳,黎海亮,等.TACE联合射频消融治疗原发性肝癌疗效的影响因素分析[J].介入放射学杂志,2012,(03):216.
 ,,et al.TACE combined with CTguided percutaneous radiofrequency ablation for the treatment of primary hepatocellular carcinomas: an analysis of factors affecting the therapeutic result [J].journal interventional radiology,2012,(03):216.
[4]张晓前,郭 鹏,党之俊,等.金龙胶囊联合介入疗法治疗原发性肝癌临床观察[J].介入放射学杂志,2012,(03):249.
 ,,et al.Kinglong capsules combined with interventional therapy for hepatocellular carcinomas: clinical observation [J].journal interventional radiology,2012,(03):249.
[5]姚红响,陈根生,诸葛英,等.肝动脉化疗栓塞联合CT引导射频消融序贯治疗中小肝癌的临床应用[J].介入放射学杂志,2012,(04):301.
 ,,et al.Sequential treatment with TACE and CTguided RFA for small and moderate sized HCC [J].journal interventional radiology,2012,(03):301.
[6]姚全军,胡鸿涛,黎海亮,等.C臂CT成像在乏血供原发性肝癌诊疗中的临床应用[J].介入放射学杂志,2012,(04):305.
 ,,et al.The clinical application of C arm CT imaging in diagnosing and treating hypovascular primary hepatic carcinomas [J].journal interventional radiology,2012,(03):305.
[7]张   磊,陆骊工,李   勇,等.门静脉支架联合肝动脉化疗栓塞治疗肝癌伴门静脉癌栓的临床研究[J].介入放射学杂志,2011,(12):968.
 ZHANG Lei,LU Li-gong,LI Yong,et al.Portal vein stent placement combined with TACE for the treatment of hepatocellular carcinoma associated with tumor thrombus in portal vein[J].journal interventional radiology,2011,(03):968.
[8]刘 昕,吕维富,鲁 东,等. 动脉介入栓塞治疗肝癌破裂出血[J].介入放射学杂志,2012,(07):586.
 LIU Xin,LV Wei- fu,LU Dong,et al. Interventional treatment of hepatic bleeding due to spontaneous rupture of hepatocellular carcinoma[J].journal interventional radiology,2012,(03):586.
[9]张志良,杨学东,温阿明,等. 经动脉化疗栓塞联合伽玛刀治疗原发性肝癌的疗效评价[J].介入放射学杂志,2012,(07):596.
 ZHANG Zhi- liang,YANG Xue- dong,WEN A-ming,et al. Evaluation of TACE combined with gamma?蛳 knife radiotherapy for primary hepatocellular carcinoma[J].journal interventional radiology,2012,(03):596.
[10]赵许亚,周 石.TACE联合经皮瘤内注射碘油吡柔比星乳剂治疗中晚期肝癌疗效分析[J].介入放射学杂志,2012,(08):675.
 ZHAO Xu- ya,ZHOU Shi.. Transcatheter artery chemoembolization combined with percutaneous intratumoral injection of Lipiodol emulsion of pirarubicin for advanced hepatocellular carcinomas: an analysis of clinical efficacy[J].journal interventional radiology,2012,(03):675.
[11]任海涛,李任飞,王月东. 原发性肝癌合并门静脉癌栓的治疗进展[J].介入放射学杂志,2013,(11):965.
 REN Hai? tao,LI Ren? fei,WANG Yue? dong.. Recent advances in the treatment of hepatocellular carcinoma with portal vein tumor thrombus[J].journal interventional radiology,2013,(03):965.
[12]李海伟,刘 静,李 森.125I粒子植入与伽玛刀治疗门脉癌栓的疗效对比[J].介入放射学杂志,2014,(08):702.
 LI Hai wei,LIU Jing,LI Sen..125Iodine seed implantation and gamma knife for the treatment of portal vein tumor thrombosis in hepatocellular carcinoma: comparison of therapeutic efficacy[J].journal interventional radiology,2014,(03):702.

备注/Memo

备注/Memo:
(收稿日期:2014-09-16)
(本文编辑:俞瑞纲)
更新日期/Last Update: 2015-03-29